首页 > 最新文献

Journal of Rheumatic Diseases最新文献

英文 中文
Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study. 类风湿性关节炎患者服用单一常规缓解病情抗风湿药(cDMARD)加抗肿瘤坏死因子药与服用多种 cDMARDs 的实际效果:一项前瞻性观察研究。
IF 2 Q3 RHEUMATOLOGY Pub Date : 2024-04-01 Epub Date: 2024-01-29 DOI: 10.4078/jrd.2023.0045
Min Wook So, Sang-Hyon Kim, Dong Wook Kim, Yoon-Kyoung Sung, Jung-Yoon Choe, Sang-Il Lee, Jin-Wuk Hur, Hye-Soon Lee, Sang-Heon Lee, Jin Ran Kim, PharmD

Objective: The objective of this prospective, observational multicenter study (NCT03264703) was to compare the effectiveness of single conventional disease-modifying anti-rheumatic drug (cDMARD) plus anti-tumor necrosis factor (TNF) therapy versus multiple cDMARD treatments in patients with moderate-to-severe rheumatoid arthritis (RA) following cDMARD failure in the real-world setting in South Korea.

Methods: At the treating physicians' discretion, patients received single cDMARD plus anti-TNF therapy or multiple cDMARDs. Changes from baseline in disease activity score 28-joint count with erythrocyte sedimentation rate (DAS28-ESR), corticosteroid use, and Korean Health Assessment Questionnaire (KHAQ-20) scores were evaluated at 3, 6, and 12 months.

Results: Of 207 enrollees, the final analysis included 45 of 73 cDMARD plus anti-TNF and 91 of 134 multiple-cDMARD recipients. There were no significant between-group differences (BGDs) in ANCOVA-adjusted changes from baseline in DAS28-ESR at 3, 6 (primary endpoint), and 12 months (BGDs -0.18, -0.38, and -0.03, respectively). More cDMARD plus anti-TNF than multiple-cDMARD recipients achieved a >50% reduction from baseline in corticosteroid dosage at 12 months (35.7% vs 14.6%; p=0.007). Changes from baseline in KHAQ-20 scores at 3, 6, and 12 months were significantly better with cDMARD plus anti-TNF therapy than with multiple cDMARDs (BGD -0.18, -0.19, and -0.19 points, respectively; all p0.024).

Conclusion: In the real-world setting, relative to multiple cDMARDs, single cDMARD plus anti-TNF therapy significantly improved quality-of-life scores and reduced corticosteroid use, with no significant BGD in disease activity, in RA patients in whom previous cDMARD therapy had failed.

研究目的这项前瞻性多中心观察性研究(NCT03264703)的目的是在韩国的实际环境中,比较单一常规改善病情抗风湿药(cDMARD)加抗肿瘤坏死因子(TNF)疗法与多种cDMARD疗法对cDMARD治疗失败的中重度类风湿关节炎(RA)患者的疗效:由主治医生决定,患者接受单一 cDMARD 加抗 TNF 治疗或多种 cDMARDs 治疗。在3、6和12个月时评估疾病活动评分28-关节计数和红细胞沉降率(DAS28-ESR)、皮质类固醇激素使用量和韩国健康评估问卷(KHAQ-20)评分与基线相比的变化:在207名患者中,最终分析包括73名cDMARD加抗TNF患者中的45名和134名多重cDMARD患者中的91名。经方差分析调整后,3、6(主要终点)和12个月时DAS28-ESR与基线相比的变化无明显组间差异(BGD)(BGD分别为-0.18、-0.38和-0.03)。12个月时,皮质类固醇用量比基线减少50%以上的cDMARD加抗TNF受试者多于多重cDMARD受试者(35.7%对14.6%;P=0.007)。3、6和12个月时KHAQ-20评分与基线相比的变化,cDMARD加抗TNF疗法明显优于多种cDMARDs疗法(BGD分别为-0.18、-0.19和-0.19分;所有P均≤0.024):结论:在真实世界环境中,相对于多种cDMARDs疗法,单一cDMARDs加抗TNF疗法能显著改善既往cDMARD疗法失败的RA患者的生活质量评分,减少皮质类固醇的使用,但疾病活动性没有明显的BGD。
{"title":"Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study.","authors":"Min Wook So, Sang-Hyon Kim, Dong Wook Kim, Yoon-Kyoung Sung, Jung-Yoon Choe, Sang-Il Lee, Jin-Wuk Hur, Hye-Soon Lee, Sang-Heon Lee, Jin Ran Kim, PharmD","doi":"10.4078/jrd.2023.0045","DOIUrl":"10.4078/jrd.2023.0045","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this prospective, observational multicenter study (NCT03264703) was to compare the effectiveness of single conventional disease-modifying anti-rheumatic drug (cDMARD) plus anti-tumor necrosis factor (TNF) therapy versus multiple cDMARD treatments in patients with moderate-to-severe rheumatoid arthritis (RA) following cDMARD failure in the real-world setting in South Korea.</p><p><strong>Methods: </strong>At the treating physicians' discretion, patients received single cDMARD plus anti-TNF therapy or multiple cDMARDs. Changes from baseline in disease activity score 28-joint count with erythrocyte sedimentation rate (DAS28-ESR), corticosteroid use, and Korean Health Assessment Questionnaire (KHAQ-20) scores were evaluated at 3, 6, and 12 months.</p><p><strong>Results: </strong>Of 207 enrollees, the final analysis included 45 of 73 cDMARD plus anti-TNF and 91 of 134 multiple-cDMARD recipients. There were no significant between-group differences (BGDs) in ANCOVA-adjusted changes from baseline in DAS28-ESR at 3, 6 (primary endpoint), and 12 months (BGDs -0.18, -0.38, and -0.03, respectively). More cDMARD plus anti-TNF than multiple-cDMARD recipients achieved a >50% reduction from baseline in corticosteroid dosage at 12 months (35.7% vs 14.6%; p=0.007). Changes from baseline in KHAQ-20 scores at 3, 6, and 12 months were significantly better with cDMARD plus anti-TNF therapy than with multiple cDMARDs (BGD -0.18, -0.19, and -0.19 points, respectively; all p<i>≤</i>0.024).</p><p><strong>Conclusion: </strong>In the real-world setting, relative to multiple cDMARDs, single cDMARD plus anti-TNF therapy significantly improved quality-of-life scores and reduced corticosteroid use, with no significant BGD in disease activity, in RA patients in whom previous cDMARD therapy had failed.</p>","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"31 2","pages":"86-96"},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10973349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Juvenile systemic sclerosis. 青少年系统性硬化症。
IF 2 Q3 RHEUMATOLOGY Pub Date : 2024-04-01 DOI: 10.4078/jrd.2024.0018
Young Dae Kim
{"title":"Juvenile systemic sclerosis.","authors":"Young Dae Kim","doi":"10.4078/jrd.2024.0018","DOIUrl":"10.4078/jrd.2024.0018","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"31 2","pages":"65-67"},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10973353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative patient's expectations and clinical outcomes after rheumatoid forefoot deformity reconstruction by joint sacrificing surgery. 通过关节牺牲手术重建类风湿前足畸形后患者的术前期望和临床效果。
IF 2 Q3 RHEUMATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-11-27 DOI: 10.4078/jrd.2023.0044
Sung-Jae Kim, Young-Woon Gil, Il-Hoon Sung

Objective: To study the clinical and radiologic factors related with overall patient satisfaction of joint scarifying reconstruction on severe rheumatoid forefoot deformity (RFD).

Methods: Forty cases of RFD were retrospectively enrolled. A questionnaire on the factors for patient's expectations and satisfactions of the greater and lesser toes was administered, including repression of relapse in deformity (D), pain reduction (P), improvement in shoe wearing (S), barefoot activity (B), and appearance (A). Overall satisfaction were assessed using the 5-digit-scale. Hallux valgus angle, 1, 2 intermetatarsal angle, and other radiologic parameters were measured. Pearson's correlation and multiple linear regression analyses were used to evaluate the relationships between these factors and overall satisfaction.

Results: Overall satisfaction was 4.0±0.82. Postoperative radiologic parameters were corrected in adequate range. Visual analog scale (VAS) was reduced from 7.2±2.1 to 2.2±1.8. For the greater toe, patient's expectations (D, P, S, B, and A) were 4.2, 4.1, 3.0, 2.5, 2.7 and satisfactions were 4.2, 4.0, 3.4, 3.5, 3.3, respectively. For the lesser toes, patient's expectations (D, P, S, B, and A) were 3.9, 4.1, 3.4, 3.0, 2.8, and satisfactions were 3.4, 4.0, 3.4, 3.6, 2.9, respectively. Satisfactions with P and B, and reduction amounts of VAS were significantly correlated with overall satisfaction.

Conclusion: Although forefoot reconstruction with a joint sacrificing procedure is non-physiological, it could be a good surgical option for severe RFD. Each patient's expectations and satisfactions with this procedure could vary. Thus, it seems important to inform patients preoperatively that expectation could be fulfilled well or less.

目的研究与严重类风湿前足畸形(RFD)患者对关节瘢痕重建总体满意度相关的临床和放射学因素:方法:回顾性纳入 40 例 RFD 病例。对患者对大、小趾的期望和满意度因素进行了问卷调查,包括抑制畸形复发(D)、减轻疼痛(P)、改善穿鞋(S)、赤足活动(B)和外观(A)。总体满意度采用 5 位数量表进行评估。测量了拇指外翻角度、1、2跖间角和其他放射学参数。采用皮尔逊相关分析和多元线性回归分析评估这些因素与总体满意度之间的关系:总体满意度为 4.0±0.82。术后放射学参数校正在适当范围内。视觉模拟量表(VAS)从(7.2±2.1)降低到(2.2±1.8)。对于大脚趾,患者的期望值(D、P、S、B、A)分别为 4.2、4.1、3.0、2.5、2.7,满意度分别为 4.2、4.0、3.4、3.5、3.3。对于较小的脚趾,患者的期望值(D、P、S、B 和 A)分别为 3.9、4.1、3.4、3.0、2.8,满意度分别为 3.4、4.0、3.4、3.6、2.9。对P和B的满意度以及VAS的减少量与总体满意度显著相关:尽管前足重建的关节牺牲手术是非生理性的,但它可能是治疗严重RFD的一个很好的手术选择。每位患者对该手术的期望和满意度可能各不相同。因此,术前告知患者期望可能会实现,也可能无法实现,这一点似乎很重要。
{"title":"Preoperative patient's expectations and clinical outcomes after rheumatoid forefoot deformity reconstruction by joint sacrificing surgery.","authors":"Sung-Jae Kim, Young-Woon Gil, Il-Hoon Sung","doi":"10.4078/jrd.2023.0044","DOIUrl":"10.4078/jrd.2023.0044","url":null,"abstract":"<p><strong>Objective: </strong>To study the clinical and radiologic factors related with overall patient satisfaction of joint scarifying reconstruction on severe rheumatoid forefoot deformity (RFD).</p><p><strong>Methods: </strong>Forty cases of RFD were retrospectively enrolled. A questionnaire on the factors for patient's expectations and satisfactions of the greater and lesser toes was administered, including repression of relapse in deformity (D), pain reduction (P), improvement in shoe wearing (S), barefoot activity (B), and appearance (A). Overall satisfaction were assessed using the 5-digit-scale. Hallux valgus angle, 1, 2 intermetatarsal angle, and other radiologic parameters were measured. Pearson's correlation and multiple linear regression analyses were used to evaluate the relationships between these factors and overall satisfaction.</p><p><strong>Results: </strong>Overall satisfaction was 4.0±0.82. Postoperative radiologic parameters were corrected in adequate range. Visual analog scale (VAS) was reduced from 7.2±2.1 to 2.2±1.8. For the greater toe, patient's expectations (D, P, S, B, and A) were 4.2, 4.1, 3.0, 2.5, 2.7 and satisfactions were 4.2, 4.0, 3.4, 3.5, 3.3, respectively. For the lesser toes, patient's expectations (D, P, S, B, and A) were 3.9, 4.1, 3.4, 3.0, 2.8, and satisfactions were 3.4, 4.0, 3.4, 3.6, 2.9, respectively. Satisfactions with P and B, and reduction amounts of VAS were significantly correlated with overall satisfaction.</p><p><strong>Conclusion: </strong>Although forefoot reconstruction with a joint sacrificing procedure is non-physiological, it could be a good surgical option for severe RFD. Each patient's expectations and satisfactions with this procedure could vary. Thus, it seems important to inform patients preoperatively that expectation could be fulfilled well or less.</p>","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"31 1","pages":"33-40"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Korean treatment recommendations for patients with axial spondyloarthritis. 更正:韩国对轴性脊椎关节炎患者的治疗建议。
IF 2 Q3 RHEUMATOLOGY Pub Date : 2024-01-01 DOI: 10.4078/jrd.2023.0025C
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim, Han Joo Baek

[This corrects the article on p. 151 in vol. 30, PMID: 37476674.].

[此处更正了第 30 卷第 151 页的文章,PMID:37476674]。
{"title":"Corrigendum: Korean treatment recommendations for patients with axial spondyloarthritis.","authors":"Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim, Han Joo Baek","doi":"10.4078/jrd.2023.0025C","DOIUrl":"https://doi.org/10.4078/jrd.2023.0025C","url":null,"abstract":"<p><p>[This corrects the article on p. 151 in vol. 30, PMID: 37476674.].</p>","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"31 1","pages":"62-63"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139076045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights from the COVID-19 pandemic: underscoring the paramount value of patient education and counseling for rheumatic diseases. 从 COVID-19 大流行中获得的启示:强调风湿病患者教育和咨询的重要价值。
IF 2 Q3 RHEUMATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-12 DOI: 10.4078/jrd.2023.0068
Byoong Yong Choi, Myeung-Su Lee, Geun Tae Kim, Seung-Jae Hong, Eun Bong Lee, Han Joo Baek
{"title":"Insights from the COVID-19 pandemic: underscoring the paramount value of patient education and counseling for rheumatic diseases.","authors":"Byoong Yong Choi, Myeung-Su Lee, Geun Tae Kim, Seung-Jae Hong, Eun Bong Lee, Han Joo Baek","doi":"10.4078/jrd.2023.0068","DOIUrl":"10.4078/jrd.2023.0068","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"31 1","pages":"59-61"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urate-lowering therapy is associated with a reduced risk of arrhythmias: a systematic review and meta-analysis 降尿酸治疗与降低心律失常风险相关:系统回顾和荟萃分析
IF 2 Q3 RHEUMATOLOGY Pub Date : 2023-12-28 DOI: 10.4078/jrd.2023.0059
Palapun Waitayangkoon, T. Leesutipornchai, W. Techasatian, Noppawit Aiumtrakul, M. Tanariyakul, Chinnawat Arayangkool, Tatchaya Kanthajan, Todd Nagamine, J. Kewcharoen
{"title":"Urate-lowering therapy is associated with a reduced risk of arrhythmias: a systematic review and meta-analysis","authors":"Palapun Waitayangkoon, T. Leesutipornchai, W. Techasatian, Noppawit Aiumtrakul, M. Tanariyakul, Chinnawat Arayangkool, Tatchaya Kanthajan, Todd Nagamine, J. Kewcharoen","doi":"10.4078/jrd.2023.0059","DOIUrl":"https://doi.org/10.4078/jrd.2023.0059","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"57 46","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139151086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery 需要透析的新发显微镜下多血管炎和肉芽肿伴多血管炎患者的肾脏预后及肾功能恢复的潜在预测因素
IF 2 Q3 RHEUMATOLOGY Pub Date : 2023-12-08 DOI: 10.4078/jrd.2023.0079
S. Ahn
{"title":"Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery","authors":"S. Ahn","doi":"10.4078/jrd.2023.0079","DOIUrl":"https://doi.org/10.4078/jrd.2023.0079","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"19 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138587843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of juvenile systemic sclerosis in Korea: 31-year single-center study 韩国幼年系统性硬化症的临床特征:为期 31 年的单中心研究
IF 2 Q3 RHEUMATOLOGY Pub Date : 2023-12-06 DOI: 10.4078/jrd.2023.0046
Ji Eun Jeong, Seong Heon Kim
{"title":"Clinical characteristics of juvenile systemic sclerosis in Korea: 31-year single-center study","authors":"Ji Eun Jeong, Seong Heon Kim","doi":"10.4078/jrd.2023.0046","DOIUrl":"https://doi.org/10.4078/jrd.2023.0046","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"60 12","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138596948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study 类风湿关节炎患者使用疾病改善性抗风湿药物接种COVID-19疫苗的临床和免疫反应:一项横断面研究
Q3 RHEUMATOLOGY Pub Date : 2023-11-10 DOI: 10.4078/jrd.2023.0054
Madhavi Eerike, Vijaya Prasanna Parimi, Anand Pyati, Raja Sundaramurthy, Varadharajan Sakthivadivel, Aswini Bramarambika Pidugu, Bhavana Surapareddy, Naga Tejaswini Ramineni, Rekha Priyadarshini, Parag Parshuram Patil
Madhavi Eerike, M.D., Vijaya Prasanna Parimi, M.D., D.M., Anand Pyati, M.D., Ph.D., Raja Sundaramurthy, M.D., Varadharajan Sakthivadivel, M.D., Aswini Bramarambika Pidugu, Pharm.D., Bhavana Surapareddy, M.D., Naga Tejaswini Ramineni, M.D., Rekha Priyadarshini, M.D., Parag Parshuram Patil, M.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2023.0054
Madhavi Eerike,医学博士,Vijaya Prasanna Parimi,医学博士,医学博士,Anand Pyati,医学博士,医学博士,Raja Sundaramurthy,医学博士,Varadharajan Sakthivadivel,医学博士,Aswini Bramarambika Pidugu,药学博士。Bhavana Surapareddy, m.d., Naga Tejaswini Ramineni, m.d., Rekha Priyadarshini, m.d., Parag Parshuram Patil, m.d.…[J]中华口腔医学杂志-0001;https://doi.org/10.4078/jrd.2023.0054
{"title":"Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study","authors":"Madhavi Eerike, Vijaya Prasanna Parimi, Anand Pyati, Raja Sundaramurthy, Varadharajan Sakthivadivel, Aswini Bramarambika Pidugu, Bhavana Surapareddy, Naga Tejaswini Ramineni, Rekha Priyadarshini, Parag Parshuram Patil","doi":"10.4078/jrd.2023.0054","DOIUrl":"https://doi.org/10.4078/jrd.2023.0054","url":null,"abstract":"Madhavi Eerike, M.D., Vijaya Prasanna Parimi, M.D., D.M., Anand Pyati, M.D., Ph.D., Raja Sundaramurthy, M.D., Varadharajan Sakthivadivel, M.D., Aswini Bramarambika Pidugu, Pharm.D., Bhavana Surapareddy, M.D., Naga Tejaswini Ramineni, M.D., Rekha Priyadarshini, M.D., Parag Parshuram Patil, M.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2023.0054","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":"99 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135092047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis 抗肿瘤坏死因子治疗对韩国强直性脊柱炎患者血脂的影响
Q3 RHEUMATOLOGY Pub Date : 2023-11-09 DOI: 10.4078/jrd.2023.0040
Inbeom Kwon, Nayeon Choi, Ji Hui Shin, Seunghun Lee, Bora Nam, Tae-Hwan Kim
{"title":"Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis","authors":"Inbeom Kwon, Nayeon Choi, Ji Hui Shin, Seunghun Lee, Bora Nam, Tae-Hwan Kim","doi":"10.4078/jrd.2023.0040","DOIUrl":"https://doi.org/10.4078/jrd.2023.0040","url":null,"abstract":"","PeriodicalId":56161,"journal":{"name":"Journal of Rheumatic Diseases","volume":" 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135243611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Rheumatic Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1